Related Experiment Video
Updated: Mar 22, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Jaegil Kim1, Kent W Mouw2,3, Paz Polak1,3,4,5
1Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Abstract:
Alterations in DNA repair pathways are common in tumors and can result in characteristic mutational signatures; however, a specific mutational signature associated with somatic alterations in the nucleotide- excision repair (NER) pathway has not yet been identified. Here we examine the mutational processes operating in urothelial cancer, a tumor type in which the core NER gene ERCC2 is significantly mutated. Analysis of three independent urothelial tumor cohorts demonstrates a strong association between somatic ERCC2 mutations and the activity of a mutational signature characterized by a broad spectrum of base changes. In addition, we note an association between the activity of this signature and smoking that is independent of ERCC2 mutation status, providing genomic evidence of tobacco-related mutagenesis in urothelial cancer. Together, these analyses identify an NER-related mutational signature and highlight the related roles of DNA damage and subsequent DNA repair in shaping tumor mutational landscape.
Insights
Researchers identified a new mutational signature linked to DNA repair in urothelial cancer. This signature is associated with ERCC2 gene mutations and smoking, offering insights into tumor development.
Area of Science:
- Genomic instability and cancer biology.
- DNA repair mechanisms and mutagenesis.
- Urothelial carcinoma and cancer genomics.
Background:
- Somatic alterations in DNA repair pathways are frequent in tumors, often yielding distinct mutational signatures.
- A specific mutational signature linked to nucleotide-excision repair (NER) pathway alterations has not been previously identified.
- The ERCC2 gene, crucial for NER, is frequently mutated in urothelial cancer.
Purpose of the Study:
- To investigate the mutational processes in urothelial cancer.
- To identify a specific mutational signature associated with somatic alterations in the NER pathway.
- To explore the relationship between this signature, ERCC2 mutations, and smoking in urothelial cancer.
Main Methods:
- Analysis of three independent urothelial tumor cohorts.
- Examination of mutational signatures associated with somatic ERCC2 mutations.
- Assessment of the association between the identified signature, ERCC2 status, and smoking.
Main Results:
- A strong association was found between somatic ERCC2 mutations and a mutational signature with a broad spectrum of base changes.
- This signature's activity was also linked to smoking, independent of ERCC2 mutation status.
- Genomic evidence supports tobacco-related mutagenesis in urothelial cancer.
Conclusions:
- An NER-related mutational signature has been identified in urothelial cancer.
- This signature is associated with both ERCC2 mutations and smoking.
- The findings highlight the interconnected roles of DNA damage and repair in shaping the tumor mutational landscape.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

